Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Oct 30, 2017

30597_dirs_2017-10-30_93831c4a-3c9f-40b4-be48-19871c6054d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-10-26

Reporting Person: Casdin Eli (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-10-26 Stock Option (right to buy) $49.33 A 10100 Acquired 2027-10-26 Common Stock (10100) Direct

Footnotes

F1: This option vests in three equal annual installments beginning on the first anniversary of the grant date.